NAD and Cellular Energy: What a Coenzyme Is and Is Not

NAD is stocked alongside research peptides but it is not a peptide, and treating it as one leads to avoidable errors in handling and in experimental design.

What it is

Nicotinamide adenine dinucleotide is a dinucleotide: two nucleotides joined through their phosphate groups. It is a small molecule, not an amino acid polymer, and it has no sequence, no termini and no secondary structure.

Two distinct roles

The first is as a redox carrier. NAD+ accepts a hydride to become NADH, and the couple shuttles reducing equivalents through glycolysis, the citric acid cycle and oxidative phosphorylation. In this role it is recycled, not consumed — the pool cycles.

The second role is as a consumed substrate. Sirtuins, PARPs and CD38 cleave NAD+ and use it up, releasing nicotinamide. This is why NAD+ availability is discussed as a limiting factor in some model systems in a way that a purely catalytic cofactor would not be: one set of enzymes recycles it and another set destroys it.

The indexed literature is at PubMed.

Handling differences from peptides

NAD+ is considerably more water-soluble than most peptides and dissolves readily without the pH manipulation that a hydrophobic sequence needs. It is, however, chemically unstable in alkaline solution, where the nicotinamide-ribose bond hydrolyses. Preparing stocks in a basic buffer — an approach that suits acidic peptides — is the wrong instinct here.

It is also light-sensitive in solution, and NADH more so than NAD+. Amber vessels and prompt use are sensible precautions.

Assay note

Because NAD+ and NADH differ in absorbance at 340 nm, the redox state of a preparation can be checked spectrophotometrically without a dedicated assay. That is a useful quick sanity check on material that has been stored in solution.

The salvage pathway, and why the precursor matters

Cells do not usually make NAD+ from scratch. The de novo route from tryptophan exists but contributes a minority of the pool in most tissues. The dominant route is the salvage pathway: nicotinamide released by the consuming enzymes is recaptured by nicotinamide phosphoribosyltransferase (NAMPT) to nicotinamide mononucleotide (NMN), and NMN adenylyltransferases convert that to NAD+.

NAMPT is the rate-limiting step, which has a direct consequence for experimental design: supplying nicotinamide to a system where NAMPT is saturated or inhibited will not raise NAD+, while supplying NMN or nicotinamide riboside bypasses that step. Precursors are therefore not interchangeable, and a study comparing “NAD+ supplementation” strategies without specifying which precursor entered where has not specified the intervention.

There is also a transport question that is easy to miss. NAD+ itself crosses plasma membranes poorly, and much of what is added to a culture is degraded extracellularly by ectoenzymes such as CD38 before it enters anything. Whether an observed effect reflects intracellular NAD+ or an extracellular degradation product is a real ambiguity, and one worth designing around rather than assuming away.

Compartmentation

NAD+ is not one pool. Cytosolic, mitochondrial and nuclear NAD+ are distinct, differ in concentration and redox ratio, and are not freely exchangeable — the inner mitochondrial membrane is impermeable to NAD+, and mammalian mitochondria import it through a dedicated transporter rather than by diffusion.

A whole-cell NAD+ measurement therefore averages compartments that may be moving in opposite directions. Where compartment matters, genetically encoded sensors targeted to each compartment give an answer that a lysate assay cannot.

The consuming enzymes

• Sirtuins — NAD+-dependent deacylases. They cleave NAD+ per catalytic cycle, releasing nicotinamide, which is itself a product inhibitor. That feedback is why nicotinamide is sometimes used as a blunt sirtuin inhibitor in cell work.
• PARPs — poly(ADP-ribose) polymerases, activated by DNA strand breaks. PARP1 in particular can consume NAD+ rapidly enough to deplete the pool under genotoxic stress, which is the mechanistic link between DNA damage and energetic collapse.
• CD38 and CD157 — NAD+ glycohydrolases, largely ectoenzymes, and a major route of extracellular NAD+ and NMN degradation.
• SARM1 — an NAD+-cleaving enzyme central to programmed axon degeneration, and the reason NAD+ metabolism appears in the neurodegeneration literature.

The practical point: any experiment perturbing NAD+ is perturbing all of these at once. Attributing an outcome to one requires either a specific inhibitor arm or a genetic manipulation, not a correlation with the NAD+ level.

Measuring NAD+ properly

• Enzymatic cycling assays are the common workhorse. They measure NAD+ and NADH separately after selective destruction of one form by acid or alkali treatment — which is exactly why the extraction chemistry has to be right.
• LC-MS/MS is the reference method, and the only one that resolves the whole metabolite panel (NAD+, NADH, NMN, NR, nicotinamide, ADP-ribose) in one run.
• The 340 nm absorbance difference between NAD+ and NADH gives a quick redox sanity check on a stock without a dedicated assay.
• Genetically encoded sensors for compartment-resolved and live-cell measurement.

Extraction is where most errors happen

The NAD+/NADH ratio changes within seconds of any perturbation, and the two forms have opposite stability profiles: NAD+ is stable in acid and destroyed in alkali, NADH the reverse. Samples that are not quenched fast and extracted into the correct medium report a ratio created by the handling rather than by the biology. Snap-freezing, cold acidic or alkaline extraction as appropriate, and consistent timing across arms are not refinements here — they are the measurement.

Handling and stability in practice

• Alkaline conditions destroy NAD+. The nicotinamide-ribose bond hydrolyses. Dilute acid or a near-neutral buffer, never a basic one — the opposite instinct to the one an acidic peptide invites.
• Both forms are light-sensitive in solution, NADH considerably more so. Amber vessels, prompt use.
• Heat accelerates degradation. Prepare cold, keep cold, and do not leave stocks at room temperature during a long plating session.
• Hygroscopic solid. The powder takes up water readily, which shifts the effective concentration of anything weighed in a humid room. Equilibrate the vial to room temperature before opening, or condensation forms inside it.
• Do not store dilute aqueous stocks. Degradation is faster the more dilute the solution. Concentrated aliquots, diluted fresh.

General conditions in storage and stability; the weighing problem in weighing lyophilised material and hygroscopicity; solvent choice in choosing a reconstitution solvent.

Why a certificate for NAD looks different

Peptide certificates are built around sequence identity and deletion impurities. Neither concept applies to a dinucleotide, and reading an NAD certificate as though it were a peptide certificate misses what matters.

• Purity by HPLC with the method stated. Detection is typically at 260 nm for the adenine chromophore rather than the 214 nm used for peptide bonds.
• Identity by mass against 663.43 g/mol for free-acid NAD+, or the corresponding salt mass if supplied as the disodium salt — a distinction that changes the amount of active material per milligram and is frequently glossed over.
• Water content. Hygroscopic and often hydrated; without a Karl Fischer figure, gross mass overstates the material. See water content and Karl Fischer titration.
• NADH contamination. A reduced fraction in nominally oxidised material changes the redox ratio you think you are adding. The 340 nm check catches it.
• Related substances — nicotinamide, ADP-ribose and NMN as degradation products, all of which are biologically active in their own right rather than inert impurities.

Terms used here

• NAD+ / NADH — oxidised and reduced forms of the dinucleotide.
• Salvage pathway — recycling of nicotinamide back to NAD+; the dominant route in most tissues.
• NAMPT — nicotinamide phosphoribosyltransferase; rate-limiting salvage enzyme.
• NMN / NR — nicotinamide mononucleotide and nicotinamide riboside; precursors entering the pathway downstream of NAMPT.
• Sirtuin — NAD+-dependent deacylase; consumes NAD+ per cycle.
• PARP — poly(ADP-ribose) polymerase; major NAD+ consumer under DNA damage.
• CD38 — ectoenzyme NAD+ glycohydrolase; degrades extracellular NAD+ and NMN.
• Compartmentation — separate cytosolic, mitochondrial and nuclear pools that do not freely exchange.

Related compounds

NAD is grouped with mitochondrial and cellular compounds alongside MOTS-c and SS-31, which are genuine peptides with unrelated mechanisms — see SS-31 and cardiolipin. Products: NAD 500mg and NAD 1000mg.

ExoLabz supplies compounds for laboratory research use only. Nothing on this page is medical advice or a suggestion of human or veterinary use. Certificates of analysis are published on this site.